Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Immediate Effects of Lumacaftor/Ivacaftor Administration on Lung Function in Patients with Severe Cystic Fibrosis Lung Disease

Immediate Effects of Lumacaftor/Ivacaftor Administration on Lung Function in Patients with Severe Cystic Fibrosis Lung Disease

Resource Type

CF Research News

Authors

Natalia Popowicz, Jamie Wood, Anna Tai, Sue Morey, Siobhain Mulrennan

References

[1] 2017 Mar 14. pii: S1569-1993(17)30075-9

Document

PDF icon CF Research News Article [2]

Link

Scientific Abstract [3]

Keywords

Ivacaftor [4]
Lumacaftor [5]
Lung function [6]
adverse events [7]

Date

Tuesday, March 14, 2017

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/immediate-effects-lumacaftorivacaftor-administration-lung-function

Links
[1] https://www.ncbi.nlm.nih.gov/pubmed/?term=Immediate+effects+of+lumacaftor%2Fivacaftor+administration+on+lung+function+in+patients+with+severe+cystic+fibrosis+lung+disease# [2] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00399R1_FINAL_Popowicz_18032017_author.pdf [3] https://www.ncbi.nlm.nih.gov/pubmed/?term=Immediate%20effects%20of%20lumacaftor/ivacaftor%20administration%20on%20lung%20function%20in%20patients%20with%20severe%20cystic%20fibrosis%20lung%20disease [4] https://www.ecfs.eu/research-article-keywords/ivacaftor [5] https://www.ecfs.eu/research-article-keywords/lumacaftor [6] https://www.ecfs.eu/research-article-keywords/lung-function [7] https://www.ecfs.eu/research-article-keywords/adverse-events [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines